← All trials
NCT00861250
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2009
- Primary completion
- Dec 1, 2014
- Completion date
- Jul 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 47
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of TampereLead sponsor
- Central Hospital of Kanta-HameCollaborator
- Seinajoki Central HospitalCollaborator
- University of TurkuCollaborator
- University of OsloCollaborator
- Johnson and JohnsonCollaborator
- University of HelsinkiCollaborator
- Kuopio University HospitalCollaborator
- University of TampereOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.